ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Coeptis Pharma Enters into Agreement to Acquire Elto Pharma
firstwordpharma
November 29, 2018Elto Phama is developing eltoprazine, a serotonergic agonist in Phase 2b development for the treatment of Parkinson's disease levodopa-induced dyskinesias (Parkinson's?LID). Elto Pharma is a joint venture between Amarantus Bioscience Holdings, Inc. (OTCPK
Pharma Sources Insight January 2025
